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 During pancreatic organogenesis, all mature cell types in the pancreas arise from 
common multipotent pancreatic progenitor cells (MPCs), localized to the distal tip of the 
expanding epithelium.  The dysfunction or destruction of pancreatic β-cells results in 
diabetes.  Endeavors to treat this disease by replacing β-cells with new cells generated 
from stem cells will benefit from exploiting the pathways involved in the normal 
development of this pancreatic cell type from MPCs.  Prior studies indicated that the 
protein β-catenin was required for the development of exocrine acinar cells, but the 
precise role of β-catenin in endocrine cell development remained controversial.  β-catenin 
also performs two separate functions, one as a crucial component of canonical Wnt 
signaling and the other at cell-cell junctions where it binds with E-cadherin to stabilize 
adherens junctions.  The purpose of this dissertation is to understand and separate the 
specific roles of β-catenin, whether signaling or structural in nature during pancreas 
development and β-cell development, particularly as it relates to the growth and 
maintenance of MPCs.  Following the elimination of all β-catenin function in the early 
pancreas, I found that β-catenin is not required for the differentiation of β-cells, but that it 
was required to establish β-cell mass.  This requirement played out not in β-cells 
themselves, but at the level of normally specified MPCs, in which β-catenin is necessary 
to both expand and maintain distal patterning in progenitors, providing a sufficient 
number of progenitors capable of producing β-cells.  To determine whether 
 
the observed growth and patterning defects were due to the signaling or structural role of 
β-catenin, I use a signaling-deficient yet structurally-competent form of the protein.  I 
found that the growth of the pancreas is dependent on the signaling role of β-catenin and 
surprisingly that patterning and exocrine acinar cell development require the structural 
role of β-catenin.   Thus, both the signaling and structural roles of β-catenin are necessary 
for separate but equally important aspects of pancreas development.   Together, the 
information presented in this dissertation provides new molecular insights into the role of 
β-catenin during pancreas and β-cell development.   
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 The prevalence of pancreatic diseases in the human population, chiefly diabetes 
and pancreatic cancer, serves as incentive for developing treatments based on the 
understanding of pancreas biology and development.  The multifunctional pancreatic 
epithelium executes both endocrine and exocrine tasks through specific functional 
domains.  The exocrine domain, which makes up the majority of pancreatic mass, 
consists of acinar cells and a highly branched ductal network that function together to 
generate and transport digestive enzymes into the intestine to assist digestion.  Pancreatic 
adenocarcinoma (PDAC), a particularly deadly cancer, arises from within the exocrine 
pancreas. The endocrine domain comprises clusters of cells named the islets of 
Langerhans which contain several cell types.  The primary function of these islet cells is 
to regulate blood glucose through the action of the majority cell type, insulin secreting 
beta-cells, and their less abundant counterparts, glucagon secreting alpha-cells.  Other 
cell types exist in islets, albeit fewer in number than either beta or alpha cells, namely 
somatostatin producing δ-cells, ghrelin producing ε-cells, and pancreatic polypeptide 
producing PP cells.  The autoimmune destruction or dysfunction of β-cells leads to 
diabetes, a prevalent and growing disease worldwide.  
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  Despite significant morphological, functional, and pathological differences, all 
pancreatic cells arise from common multipotent pancreatic progenitor cells (MPCs)1,2.   
The specification, maintenance, and expansion of these MPCs is crucial to the proper 
formation of the adult pancreas, as shown by the development of a smaller and 
dysfunctional organ following early partial ablation of progenitors3.  Critical aspects of 
the instructional program that directs MPC specification, maintenance, self-renewal, and 
finally fate decision throughout pancreatic organogenesis and homeostasis will be 
addressed in this thesis.  A special emphasis will be placed on the endocrine pancreas and 
the role of the signaling and structural protein β-catenin during pancreas development, 
with an end-goal of understanding β-cell development for the purpose of generating cell-
based therapies for diabetics.   
 
Diabetes 
 Diabetes mellitus can be characterized as a metabolic disease caused by reduced 
insulin functionality that results in high blood glucose leading to serious health concerns. 
As a disease family, diabetes can be etiologically subdivided into type 1 and type 2 
diabetes (T1DM and T2DM, respectively).   Although both T2DM and T1DM are both 
the result of elevated blood glucose, the causes of these two subforms differ greatly.  In 
type 1 diabetes, autoimmune destruction of β-cells results in insulin insufficiency, leading 
to elevated blood sugar that usually manifests in juveniles.  In contrast, TD2M is not a 
disease of the pancreas per se, but rather stems from insulin resistance in skeletal muscle 
and adipose tissue, with strong correlation to obese and aged individuals.  The inability of 
these nonpancreatic tissues to recognize insulin signals leads to the inability to uptake 
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glucose and subsequent elevated blood glucose.  Eventually, T2DM leads to insulin 
deficiency and reduced β-cell mass, likely due to added stress placed on β-cells to secrete 
more insulin to resistant tissues4,5.    
 Even though the origin and causes for each of these diseases differ, both forms of 
diabetes are increasing dramatically in prevalence.  In the United States alone, due to 
unspecified reasons, T1DM increased by 23% from 2001 to 2009, with approximately 3 
million people currently living with the disease.  An even more disturbing trend exists in 
relation to T2DM in which over 10% of people over 20 years old have diabetes with 
another 80 million people being considered prediabetic.  As a whole, diabetes cost $245 
billion dollars in 2012 and diabetics on average spent over two times the amount of non-
diabetics on healthcare 6,7.  Moreover, persons living with diabetes must constantly 
monitor blood glucose, and must often supply exogenous insulin in order to properly 
maintain glucose homeostasis. Therefore, developing more cost-effective and more 
permanent treatment options for diabetics is of significant importance.  β-cell 
replacement has been proposed as a potentially curative treatment; however, obtaining 
sufficient β-cells poses a significant challenge. 
 
Sources of β-cells  
 To date, the only successful β-cell replacement therapies involve transplantation 
of cadaver tissue, either isolated islets or whole pancreas.  Whole pancreas 
transplantation is a relatively new procedure with success rates comparable to other organ 
transplants.  In fact, most T1DM transplant recipients are no longer insulin-dependent for 
several years following surgery 8.  However, whole pancreas transplants are complicated 
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and are only performed in combination with kidney transplantation in diabetics with end-
stage renal disease.  Furthermore, immunosuppressant therapies must be employed to 
avoid organ rejection, leading to weakened immune response.  As an alternative to whole 
pancreas transplants, islets can be isolated from whole pancreata and successfully 
transplanted into T1DM patients by following a procedure known as the Edmonton 
protocol 9.  Although less invasive than whole organ replacement, obtaining cadaver 
islets is not a trivial process and in fact, 3-4 donor organs must be harvested in order to 
obtain sufficient numbers for a single transplantation.  While outcomes are nearly 100% 
efficacious within the first year, islet function decreases in subsequent years, often 
necessitating another round of islet transplantation10,11.  The short-term success of 
transplantation combined with the difficultly of obtaining sufficient quality islets 
provides incentive to identify potential nondonor sources of β-cells, including self-
replication, neogenesis, and in vitro differentiation.  
 Perhaps the most straightforward source of new β-cells is to induce pre-existing 
β-cells to proliferate.  Justifying this approach are studies indicating that self-replication 
is the main driver of expansion and regeneration of β-cells following depletion or during 
instances of high metabolic demand such as obesity and during pregnancy 12-15.  Several 
molecules and mechanisms have been identified that can encourage and regulate β-cell 
proliferation; however, the efficacy of each molecule is dependent upon specific genetic 
or physiological conditions and do not ubiquitously increase β-cell mass 5.  Moreover, in 
T1DM, β-cell mass is dramatically reduced and the lack of starting material may not 
allow for sufficient β-cell self-replication, necessitating other sources of starting material.    
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 The adult pancreas exhibits phenotype plasticity between differentiated cell types. 
This is well demonstrated in pancreatic cancer, where exocrine acinar cells undergo 
metaplasia turning into duct-like cells that later give rise to cancerous lesions 16.  The 
same plasticity that allows for such transformation could be harnessed to reprogram other 
pancreatic cell types or adult pancreatic progenitors into β-cells.  Acinar cells, partly 
because they are directly derived from multipotent progenitor cells (MPCs), and partly 
because they are the most abundant cell type in the pancreas, represent a large population 
with the potential to become β-cells, but do so only after having been transduced with β-
cell-specific transcription factors 17.   Glucagon secreting α-cells have also been shown to 
reprogram into β-cells, after the ectopic expression of the β-cell-specific transcription 
factor Pax4 18 and after near complete β-cell ablation 19.  Regardless of the source of cells 
that might be reprogrammed into β-cells, the ability to induce such transformation 
without dramatic external manipulation is not possible at present.   
 A major challenge of β-cell replacement via transplantation, replication, or 
neogenesis is whether any of these methods can efficiently produce sufficient numbers of 
β-cells to maintain glucose homeostasis.   The in vitro generation of β-cells from 
pluripotent stem cells (embryonic stem cells or induced pluripotent stem cells) serves as a 
potential solution to this problem, providing, in essence, an endless supply of cells for 
transplantation.  Essential transcription factors needed for β-cell development have been 
identified; however, introducing foreign DNA constructs to drive expression of these 
transcription factors carries with it unknown consequences, including potential disruption 
of other essential genes.  Current pluripotent stem cell differentiation protocols involve 
step-wise differentiation first into definitive endoderm, then foregut, followed by 
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pancreatic fate and finally, hormone-producing endocrine cells 20.   Importantly, these 
protocols do not involve the introduction of DNA-constructs, but rather rely on precise 
temporal administration of recombinant signaling proteins 21. However, even though 
functional glucose-sensing β-cells cells differentiate in vivo from the engraftment of 
pancreatic endocrine progenitors, in vitro differentiated β-cells often lack the ability to 
sense and respond to glucose  20,22.   These advances suggest that deriving β-cells from 
stem cells is indeed possible.  Nevertheless, there are many facets of in vivo β-cell 
differentiation and maturation that remain poorly characterized, preventing the 
development of such cell-based treatments.  The signaling pathways and interactions that 
guide pancreas development from progenitor through functional mature pancreatic cells 
remain particularly elusive.  Further study of in vivo pancreas development is necessary 
to enhance efforts to drive stem cell differentiation into β-cells. 
 
 Mouse pancreas development 
 In mice, the first morphological evidence of pancreas development occurs around 
embryonic day 9.5 (E9.5), when evaginating ridges of foregut endoderm emerge bi-
directionally into pancreatic mesenchyme to form a pair of dorsal and ventral pancreatic 
buds.  Preceding this morphological change is the expression of the transcription factor 
pancreatic and duodenal homeobox 1 (Pdx1) at ~E8.5.  Based on the almost complete 
pancreatic agenesis observed in its absence, Pdx1 was the first gene discovered as a 
master regulator of pancreas development 2,23-26.  Shortly after specification, all 
pancreatic progenitors (MPCs) express Pdx1, and a different but equally crucial 
transcription factor, pancreas transcription factor 1-a (Ptf1a) 27.  Ptf1a further specifies 
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pancreatic fate over other endodermal fates in Pdx1 is expressing cells 28, and is likewise 
essential for proper pancreas development and expressed by MPCs 29. These two 
transcription factors together help instigate the pancreas developmental program, and 
lineage tracing experiments show that all pancreatic cell types arise through Pdx1 and 
Ptf1a expressing progenitors. 1,28,30,31.  Following specification, during a period called the 
primary transition, concomitant with high levels of proliferation and the appearance of 
endocrine α-cells, the mouse pancreatic epithelium undergoes a major morphological 
change where pancreatic buds spatially stratify into two distinct domains, distal “tips” 
and proximal “trunks”,  a process henceforth referred to as patterning.  The newly 
patterned epithelium expands into the pancreatic mesenchyme, which secretes signaling 
factors necessary for growth, patterning, and allocation of progenitors into differentiated 
fates 2,32 (Fig. 1.1).  The distal tips contain MPCs, while proximal trunks contain MPC 
derived bi-potent progenitors that give rise to endocrine islets and duct cells.  MPCs 
produce all pancreatic lineages until approximately the beginning of the secondary 
transition at E13.5, after which distal MPCs are restricted to an acinar fate 1.  Bi-potent 
progenitors, on the other hand, produce both ducts and islets throughout in utero 
development 33.  The decision between duct and islet is marked by the expression of the 
transcription factor neurogenin-3 (Ngn3), which is expressed throughout in utero 
development by endocrine precursors 30,34,35.   Importantly, trunk cells that express high 
levels of Ngn3 comprise a nondividing, endocrine-committed precursor population that 
directly differentiates into endocrine cells, after which they regain proliferative abilities 2.  




Figure 1.1: Pancreas lineages and development.  Pancreas lineages and 
development are depicted schematically.  (A)  All pancreatic lineages arise from 
MPCs that express the transcription factor Pdx1.  The division between Ptf1a+ distal  
and proximal domains is represented by the blue dashed line.  Proximal trunks give 
rise to ducts and Ngn3+ endocrine precursors.  (B)  Cartoon schematic showing the 
morphology and stages of pancreas development.  The black arrows indicate 
proliferation.  The division between distal and proximal is represented by the blue 
dashed line.  The semicircular arrows represent proliferation.   
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differentiation of MPCs to all other pancreatic cell types 2; however, the upstream 
signaling events that control these transcriptional changes remain less understood. 
 
 
Signaling pathways and pancreas development 
 As signaling pathways mediate communication between cells and responses to the 
cellular environment, manipulating them could potentially affect stem cell differentiation 
extrinsically.  Nevertheless, signal transduction pathways must act in a strict 
spatiotemporal fashion to bring about various aspects of organogenesis. Several signaling 
pathways, including Notch, Wnt, Fibroblast Growth Factor (FGF), and retinoic acid 
(RA), participate in pancreas development 2.   Perturbations in the Notch signaling 
pathway illustrate critical context-specific control of early pancreas development and 
lineage allocation.   Early studies of the pathway associated Notch signaling as an 
inhibitor of pancreatic endocrine differentiation 36,37 and later studies further 
demonstrated that Notch also inhibited acinar cell development 38-40.  These observations 
support recent reports that advocate a role for Notch in modulating distal-proximal 
patterning, wherein Notch promotes proximal/bipotent fate over distal/MPC fate, and 
duct over endocrine fate in bipotent trunk progenitors 41-43.  However, Notch is but one of 
many signaling pathways involved in pancreas development, and a major gap exists in 
understanding how multiple signaling pathways communicate to bring about the complex 
morphological and fate decisions of pancreatic organogenesis.   Chapter 2 of this thesis 
specifically addresses the interaction of Notch signaling and β-catenin, a nonredundant 





 First described as wingless signaling in Drosophila 44, Wnt signaling is involved 
in the normal development of most metazoan tissues, and perturbations in the pathway 
contribute to human diseases, possibly including pancreatic cancer and diabetes 45. Wnt 
ligands are secreted and bind to specific receptor combinations to activate signaling.  
Traditionally, Wnt signaling is divided into canonical and noncanonical signaling 
pathways, which require specific Wnt ligand and receptor combinations.  In the absence 
of a Wnt ligand, cytoplasmic β-catenin is degraded by a complex partly consisting of 
APC, Axin, and the kinase GSK3.  The phosphorylation of β-catenin by GSK3 results in 
the ubiquitinization of β-catenin and proteosomal destruction.  Following Wnt ligand 
binding to LRP5/6 and Frizzled receptors, the protein Disheveled is activated, which 
causes complex disassembly, release of β-catenin, and accumulation of unphosphorylated 
β-catenin in the cytoplasm.  When the levels of accumulation reach an unknown 
threshold, some β-catenin enters the nucleus where it binds to specific members of the 
Tcf/Lef family of transcription factors, displacing transcriptional repressors and 
recruiting transcriptional co-activators eventually culminating in the transcription of 
specific target genes 45.  
 Study of vertebrate Wnt signaling has been hampered by the redundancy 
signaling elements including Wnt ligands (19 in mice) and Frizzled receptors (10 in 
mice). However, the canonical Wnt signaling pathway requires β-catenin regardless of 
the many ligand-receptor combinations that may exist, and perturbations of this single 
molecule allow for more straightforward pathway manipulation in the Wnt receiving 
cell45,46.  Likewise, in Wnt sending cells, eliminating the function of the Wnt modifying 
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proteins Porcn or Evi effectively prevents the secretion of Wnt ligands47.  Thus, abolition 
of Wnt/β-catenin signaling can be accomplished by either deleting β-catenin in receiving 
cells, or in Wnt secreting cells through the deletion of Porcn or Evi.    
 
 
Wnt/β-catenin in the pancreas 
   
 Wnt/β-catenin signaling is required for the expansion, differentiation, and 
maintenance but not for the specification of the pancreatic epithelium46,48.  The purpose 
of this thesis is to uncover the mechanisms through which β-catenin instructs progenitor 
differentiation into the various pancreatic lineages.  During early development of the 
pancreas in mice, Xenopus, and zebrafish, activation of the Wnt pathway appears to 
prevent pancreas development at the level of specification, by pushing early specified 
pancreatic progenitors away from a pancreatic fate toward other endodermal fates 46,49.  
In mice, this is highlighted by a study that demonstrated that prior to E11.5, activation of 
β-catenin with an early acting Pdx1-Cre transgene  (Pdx1-Creearly) led to severe 
pancreatic hypoplasia, whereas activation with the later-acting “Pdx1-Crelate” transgene 
led to the opposite phenotype, a hyperplastic organ, mainly due to increased acinar cell 
number 48. 
 In contrast to the early activation of Wnt/β-catenin signaling, inhibition of Wnt 
pathway activity through the expression of a dominant-negative Frizzled8 Wnt receptor 
did not disrupt pancreas specification, but produced an overall smaller organ 50. Prior 
studies using Pdx1-Creearly transgenes to delete β-catenin from the early embryonic 
pancreas found mutant pancreata to be significantly smaller than littermate controls and 
severely deprived of acinar cells; nevertheless, a qualitatively normal number of 
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endocrine β- and α-cells were present 51,52.  Moreover, somewhat similar acinar 
hypoplasia was observed after deleting the Wnt target gene c-Myc 53,54, supporting a 
Wnt/β-catenin-dependent pancreatic growth model.  Conversely, following the deletion 
of β-catenin using the Pdx1-Crelate transgene 48, which acts several days later than Pdx1-
Creearly, acinar cells developed normally but islet cell number was slightly decreased 55, 
suggesting that β-catenin was required by endocrine but not exocrine cells for growth and 
expansion later in development. These seemingly conflicting reports are likely the result 
of the temporal efficacy of Cre-mediated recombination in the two different strains 46.  
Moreover, during the postnatal period and during regeneration from pancreatitis-induced 
injury, β-catenin is required for acinar cell proliferation 56.  Whether Wnt/β-catenin 
signaling is required for endocrine cell development and expansion remains somewhat 
controversial: where some data suggest it is required for the expansion of endocrine cells 
57,58, a separate study indicates that it is dispensable for β-cell proliferation 56.  Therefore, 
the precise roles of β-catenin during pancreas development, particularly as it relates to 
establishing endocrine β-cell mass, remain to be unraveled.  Chapter 2 of this thesis 
specifically addresses this question through extensive spatiotemporal analysis of β-
catenin deficient pancreata.   
 
β-catenin as a structural protein 
 The signaling function of β-catenin was first described in Drosophila by the 
identification of its homolog armadillo, a component of wingless signaling 59.  During the 
same period, β-catenin was biochemically isolated, together with α-catenin and γ-
catenin/plakoglobin, as a binding partner for E-cadherin, and the cadherin-catenin 
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complex was proposed to bridge the actin cytoskeleton of adjacent cells to stabilize and 
polarize epithelial sheets 60,61. These two distinct roles for β-catenin/armadillo may 
control different aspects of cellular behavior as shown in studies in both Drosophila and 
mice 61-63. In pancreas development, changes to polarity and actin dynamics lead to 
precise morphological rearrangements that are necessary for epithelial patterning 64 and 
mutations in actin remodeling proteins can lead to defects in epithelial organization and 
cell differentiation 65-67. Thus, a structural role for β-catenin is plausible in the pancreas, 
yet separating the structural and signaling functions of β-catenin has been challenging in 
this organ and elsewhere because Tcf/Lef and transcriptional co-activator binding 
domains overlap with the E-cadherin and α-catenin binding domains (Fig. 1.2).  The 
central region of the β-catenin protein, made up of several armadillo repeats, is required 
for both signaling and structural functions, while the flanking N and C-terminal domains 
are required to recruit transcriptional co-activators 68-71.   
 Even though obvious considerations must be paid to potential defects in cadherin-
binding/structural integrity in studies eliminating β-catenin function, most have 
concentrated only on its role in Wnt signaling. For example, numerous mouse studies 
investigating tissue-specific Cre-mediated deletion of β-catenin have been mainly 
focused on its signaling role 72.  Recently, through the introduction of two separate 
mutations based on binding domain characterization, Konrad Basler and his colleagues 
created a Wnt signaling-deficient, yet structurally-competent form of β-catenin 
(βCATdouble-mutant or βCATDM).  This important study demonstrated that the signaling and 
structural roles of β-catenin were both essential for neural tube development 63, a 




Figure 1.2:  The signaling and structural binding domains of β-catenin.  β-catenin 
comprises an N-terminus, 12 armadillo repeats (colored boxes), and a C-terminal 
domain. (A)  Wildtype β-catenin (βCATWT) binds to transcriptional co-activators at 
the N- and C-terminus of β-catenin, and to Tcf/Lef in the internal armadillo repeat 
region (blue squares).  β-catenin binds to E-cadherin in the armadillo repeats and to α-
catenin at the N-terminal side of the armadillo repeat region (green square).  
(B)  βCATDM mutants are truncated at the C-terminus and mutated D164A at the N-
terminus (yellow lightning bolts) and no-longer bind transcriptional co-activators(red 
lettering), but still retain E-cadherin and α-catenin binding domains.   
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demonstrate that the signaling and structural functions of β-catenin also control different 
aspects of pancreas development. 
    
 
Summary 
 The loss of functional β-cells or response to insulin leads to diabetes, and the 
number of both type 1 and type 2 diabetics is dramatically increasing worldwide.  
Replacing lost or dysfunctional β-cells through transplantation, self-replication, or 
neogenesis from existing acinar tissue is limited by the efficiency of each method to 
restore adequate β-cells to restore glucose homeostasis.  In vitro differentiation of β-cells 
from stem or progenitor cells could provide a potentially endless supply of functional 
cells.  However, due to a lack of understanding of the in vivo mechanisms involved 
during their development, no fully functional β-cells have been generated in vitro. 
Therefore, a better understanding of the signaling and downstream transcriptional 
changes that guide the expansion and differentiation of pancreatic progenitors is needed.  
 Multipotent pancreatic progenitors (MPCs) are capable of giving rise to all 
pancreatic lineages through the early phases of development 1 and the number of MPCs 
determines the final size of both the exocrine and endocrine pancreas.  However, unlike 
acinar cells, endocrine cells do not directly arise from MPCs; rather, they arise via MPC-
derived bipotent progenitors.  Each progenitor pool, MPCs or their bipotent offspring, 
occupies a specific niche within the pancreatic epithelium, with MPCs being found at the 
distal tip and bipotent cells found in proximal trunks.  Maintaining this distal-proximal 
patterning along with their ability to self-renew is crucial to the development and final 
volume of pancreatic β-cells.   
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 Previous studies indicate that the signaling and structural protein β-catenin is 
necessary for the embryonic differentiation, postnatal growth, and adult regeneration of 
exocrine acinar cells but not for pancreatic endocrine cells 51,52,55.  Nonetheless, the 
precise role of β-catenin in the regulation of MPCs and in other pancreatic lineages 
remains unknown and in the case of β-cells, remains controversial.  Potentially 
complicating such studies is the fact that β-catenin is a multifunctional protein, 
participating in canonical Wnt signaling pathway as well as constituting a structural 
component of E-cadherin junctions.  The work presented in this thesis centers on the 
roles of β-catenin during early mouse pancreas development.  I specifically address the 
roles of β-catenin in maintaining distal-proximal patterning and progenitor expansion 
and, through the use of unique genetic tools, dissect the signaling and structural roles of 
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CHAPTER 2  
 
DISTINCT REQUIRMENTS FOR BETA-CATENIN  
IN PANCREATIC  EPITHELIAL  
GROWTH AND PATTERNING 
 
Reprint with permission of: Baumgartner, B.K., Cash, G., Hansen, H., Ostler, S., 
Murtaugh, L.C. (2014). Distinct requirements for beta-catenin in pancreatic epithelial 






































SUPPLEMENTARY FIGURE LEGENDS  
Supplementary Figure 1: β-cell size is unchanged in the absence of β-catenin. (A-C) 
β-cell size at E17.5 was calculated by dividing the area of insulin staining (red) by the 
number of overlapping DAPI+ cells (blue). (A-B) E17.5 β-cells in controls and PBKO 
appear similar in size. (C) No significant β-cell size difference was found between 
control and PBKO at E17.5.  
  
Supplementary Figure 2:  β-catenin maintains epithelial proportions of distal tips 
and Ngn3+ cells.  E12.5 pancreata were stained with E-cadherin to label all cells, Ptf1a 
to label distal tips and Ngn3 to label endocrine precursors.  (A) The percentage of all 
pancreatic E-cadherin+ cells that were also Ptf1a+ decreases in PBKOs compared to 
controls.  (B) The percentage of Ngn3+ cells found within the trunk epithelium (Pft1a-, 
E-cadherin+) was increased in PBKOs compared to controls, suggesting a shift toward 
proximal trunk/endocrine fate in the absence of β-catenin.    
  
Supplementary Figure 3: Sox9 expression is unchanged in the absence of β-catenin.  
E12.5 pancreata were stained with Sox9 and E-cadherin. (A) Controls show nearly 
ubiquitous staining of the pancreatic epithelium (green) with Sox9 (red) at E12.5, with 
staining absent from likely αcells (arrowhead). (B) Sox9 staining shown without E-
cadherin in (A).  (C-D) Staining of PBKOs appears similar to controls.    
  
Supplementary Figure 4: E13.5 α-cell number in the absence of β-catenin. (A-B) 
E13.5 pancreatic epithelia were stained for glucagon (brown) to label α-cells. Control 
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pancreata contain centrally located α-cells, while α-cells appear to be distributed more 
widely in PBKO pancreata.  (C) Quantification of total glucagon+ volume (present 
through the entire pancreas) indicates that PBKO pancreata trend toward a slight increase 
in α-cell mass (P=0.17).  
  
Supplementary Figure 5:  Mosaic deletion confirms that β-catenin is dispensable for 
β-cell differentiation.  Control (Ctnnb1lox/+; R26REYFP/+, Pdx1-CreERT/+) and mPBKO 
(Ctnnb1Δ/lox; R26REYFP/+, Pdx1-CreERT/+) embryos received tamoxifen in utero at E10.5, 
and were harvested at E17.5.  (A-C) Staining for amylase (red) reveals dramatically 
decreased EYFP labeling (green) in mPBKO compared to control.  (D-F) EYFP labeling 
































DEFINING THE SIGNALING AND STRUCTURAL 




 β-catenin is an evolutionarily conserved protein that regulates a vast number of 
processes in metazoans, from gastrulation through organogenesis during development as 
well as stem cell and metabolic homeostasis in adults 1.   β-catenin accomplishes such 
control through two distinct functional mechanisms, one structural and one signaling in 
nature.  In epithelial cells, β-catenin functions as a component of cadherin-based cell-cell 
junctions, in which it binds to E-cadherin and α-catenin, thereby linking, polarizing, and 
stabilizing actin filament structures across neighboring cells 2.  The other central role of 
β-catenin is in canonical Wnt signaling, in which the presence of Wnt ligands causes 
accumulation of cytoplasmic β-catenin, which enters the nucleus, binds to TCF/LEF 
transcription factors, and recruits transcriptional co-activators to effect changes in gene 
expression.   The majority of genetic studies of β-catenin in mice involve the tissue-
specific ablation of all β-catenin function, producing a wide variety of developmental and 
adult phenotypes 4. However, the majority of these studies focus on the Wnt signaling 
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role of β-catenin and, partly due to the lack of appropriate genetic tools, failed to address 
changes in cell-cell adhesion that could explain the observed phenotypes.  
 Careful characterization of mutations in Drosophila armadillo, the β-catenin 
homologue, revealed some mutations that affected either signaling or structural functions 
but not both 5, indicating that the signaling and structural functions of Armadillo/β-
catenin could be separated.  Using information gleaned from mapping such mutations, 
along with binding domain analysis, a signaling-deficient, structurally-competent allele 
of β-catenin was developed in the laboratory of Konrad Basler 6.  By mutating a single 
residue at the N-terminus as well as truncating the C-terminus of the protein, regions 
required to recruit transcriptional co-activators, this group created a signaling-deficient 
allele of β-catenin (β-catenin-double-mutant, Ctnnb1DM), and found that the signaling and 
structural roles of β-catenin act separately to control the maintenance, expansion, and 
differentiation of neural progenitors 6.   Whether other developmental processes 
previously attributed to the Wnt signaling function of β-catenin are also regulated wholly 
or in part by its structural role is unknown.   Among these is the role of β-catenin in the 
developing and adult pancreas, previously studied by our lab and others 7. 
 We have demonstrated that β-catenin is required for development, postnatal 
expansion, and regeneration of exocrine acinar cells, but that β-cells differentiate, 
function, and replicate normally in the absence of any β-catenin activity8,9.  Despite the 
normal differentiation and function of β-cells, my recent work on β-catenin-deficient 
pancreata (Chapter 2) revealed a previously-unrecognized requirement for β-catenin in 
multipotent progenitor cells (MPCs), prior to endocrine specification, to generate normal 
islet cell numbers.  Furthermore, I found that β-catenin performs two distinct functions in 
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the early pancreatic epithelium where it (1) maintains distal-proximal patterning 
following organ specification and (2) promotes proliferation driving pancreas growth 3.   
However, our previous studies were performed using pancreata in which both the 
signaling and structural functions of β-catenin had been eliminated.  Thus, which function 
of β-catenin controls early distal-proximal patterning, acinar differentiation, and distal-
acinar cell proliferation remains unknown. 
 In fact, recent studies indicate a role for epithelial and cytoskeletal rearrangements 
in the developing pancreas, in which β-catenin might participate via its structural function 
10-12.  Reorganization and stratification of the newly specified pancreatic epithelium is a 
necessary morphological change that establishes two specific domains, distal/tip cells and 
proximal/trunk cells.  Tip cells, so-called for their peripheral location in the developing 
pancreas, contain the MPCs that produce all pancreatic lineages until the occurrence of 
the secondary transition at E13.5 13,14.  Trunks cells, by contrast, function as bi-potent 
endocrine and duct progenitors.  Thus, establishing distal-proximal division of the 
developing pancreas is crucial to its mature functionality.  My previous work (Chapter 2) 
demonstrated that β-catenin is required for maintaining distal tip MPCs, supporting 
development of both exocrine and endocrine lineages. In the present study, we readdress 
the mechanistic roles of β-catenin during pancreas development and postnatal acinar cell 
growth, and demonstrate that its signaling and structural functions likely control different 






Materials and methods 
Mice 
 All experiments were performed according to protocols approved by the 
University of Utah Institutional Animal Care and Use Committee.  We obtained 
signaling-specific β-catenin mutant mice (Ctnnb1tm3Kba, referred to as Ctnnb1DM) from 
Konrad Basler (University of Zurich) 6. Several other mouse strains were purchased from 
the Jackson Laboratory: floxed and germline β-catenin loss-of-function mice 
(Ctnnb1tm2Kem/J and Ctnnb1tm2.1Kem, henceforth Ctnnb1lox and Ctnnb1Δ, respectively)15; 
Ngn3-Cre BAC transgenic mice 16 and the Cre-dependent EYFP reporter strain 
Gt(ROSA)26Sortm1(EYFP)Cos 17.   Pdx1-Cre, Pdx1-CreERT 18 and Elastase-CreERT (Ela-
CreERT) 19 transgenic mice were provided by Doug Melton (Harvard University).  To 
induce recombination with Pdx1-CreERT or Ela-CreERT, we administered tamoxifen 
(Sigma) suspended in corn oil, by oral gavage. Embryos were genotyped by PCR, using 
primer sets described previously 6,9,18. 
 
Tissue processing and staining 
 Pregnant dams were anesthetized with isoflurane and euthanized by cervical 
dislocation.  Whole embryos (E13.5 and younger) and pancreata (E14.5 through 
adulthood) were dissected into ice-cold PBS for processing.  Tissues were fixed 
overnight at room-temperature with zinc-buffered formalin (Polysciences) for paraffin 
sections or with 4% paraformaldehyde/PBS (2 hours-overnight at 4°C for frozen 
sections), and further processed as previously3,8,20.   Series of duplicate paraffin sections 
(6 µm) were collected sequentially across multiple slides, spaced with skipping to span 
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the entire pancreas as described previously 3. For labeling S-phase nuclei, mice were 
injected with BrdU (50 µg/g body weight) 1 hour prior to sacrifice.    
 Antibodies used for immunostaining are listed in Chapter 2 3, and all secondary 
antibodies (raised in donkey) were purchased from Jackson Immunoresearch.  
Immunostaining was performed as described previously 3,8,20, including high-temperature 
antigen retrieval for paraffin sections.  For anti-BrdU staining, frozen sections were pre-
treated with DNAse I (700 u/ul, in 40 mM Tris-HCl pH 7.4, 10 mM NaCl, 6 mM 
MgCl2,10 mM CaCl2) at room temperature for 30 minutes 21.  Bright field images were 
obtained using an Olympus CX41 microscope and MicroSuite software. For 
immunofluorescence, Fluoromount-G (Southern Biotech) was used as a mounting 
substrate and images were obtained using an Olympus IX71 microscope and MicroSuite 
software.  Identical exposure times and postprocessing adjustments performed in Adobe 
Photoshop were used across control and experimental genotypes.   
 
Quantification and analysis 
 To determine β-cell mass, pancreas size, and volume or number of cells 
expressing various markers, serial sections were stained by immunohistochemistry, and 
all sections on a single slide were photographed individually, to provide a representation 
of  the entire pancreas. Cell counts, surface area, lineage tracing, and other quantification 
were performed using Photoshop count tool or ImageJ as previously described in Chapter 
2 3,8,20. Calculations, graphs, and P-values (two-tailed, unpaired t-test) were generated in 




Modeling pancreas growth 
 To model pancreas growth, we used the exponential growth equation 
N(t)=N(0)*e(r*t), where N(t) represents the final population after a period of t days and 
N(0) represents the initial population.  The growth constant r, the rate at which the 
control pancreas expands over a day (resc), was calculated by substituting known values 
for pancreas size at E14.5 and E17.5 for N(0) and N(t), respectively.  To determine the 
growth constant r for mutant cells (rmut), resc was divided by the ratio of proliferation 
between control and mutant cells (BrdU labeling of control cells was 1.32-fold higher 
than that of mutant cells). The simulation was started at E14.5 using the known values of 
escaper (non-recombined) and mutant cells for the initial population (N(0)) of each 
group.  Finally, the predicted number of escaper cells at day t was divided by the sum of 
the total predicted population of escapers and mutant cells.  To model size, we used the 
growth constants generated for each population and back-calculated the percentage of 
escapers at E11.5, a point we previously determined to be unaffected by the loss of β-
catenin 3 and started the simulation with both controls and PBsKO (described in Fig 
1.1A)  being the same.   
 
Explant cultures and wholemount immunostaining 
 For ex vivo explant cultures, the dorsal buds of E11.5 pancreata were dissected in 
ice-cold sterile PBS, and cultured at the air-media interface for 3 days as described in 
Chapter 2 3. A small piece of tissue was collected for genotyping purposes at the time of 
dissection.  β-catenin signaling-deficient explants (PBsKO) and their controls received no 
drug treatment. Pancreatic and kidney explants from E11.5 wild-type embryos were 
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treated with the PORCN inhibitor IWP-2 (Tocris 3533), 5 µM in DMSO, while controls 
received DMSO only treatment.  Media was changed daily. 
 Wholemount immunofluorescence was performed as previously described in 
Chapter 2 3,20. Briefly, explants were fixed overnight in 4% PFA, washed, and stored in 
methanol until staining.  For staining, explants were incubated in Dent’s bleach for 2-4 
hours, rehydrated to PBS, treated for 1 hour with PBS + 1% Triton-X100, and then 
placed in pre-block for 2 hours.  Primary and secondary antibody incubations were 
performed overnight at room temperature. Confocal images were obtained using an 
Olympus FV-1000 microscope. 
 
Results 
β-catenin signaling regulates pancreas growth 
 Previously, we generated pancreas-specific β-catenin knockout mice (PBKO) 3,9 
by deleting the conditional Ctnnb1lox 15 allele with the Pdx1-Creearly transgene (referred to 
here as Pdx1-Cre) 18, in mice also carrying the germline Ctnnb1Δ 15 mutation, resulting in 
a pancreas devoid of any β-catenin function.  To produce pancreas-specific β-catenin 
signaling-deficient mice (henceforth PBsKO), we likewise deleted Ctnnb1lox with Pdx1-
Cre, but replaced the germline null Ctnnb1Δ allele with the germline β-catenin signaling-
deficient allele Ctnnb1DM  6(Fig. 3.1A).   Similar to previous results from PBKO studies, 
PBsKO pancreata at the late fetal stage of E17.5 were much smaller than controls at the 
gross level (Fig. 3.1B-C).   Our earlier characterization of PBKO mice provided clear 
evidence that β-catenin function is necessary for acinar cell development, and that a 
dramatic loss of exocrine tissue underlies the observed pancreatic hypoplasia 3,9,22.  By 
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using methods we developed to quantify absolute cell volume from stained sections, we 
found the total epithelial volume of PBsKO pancreata was reduced >3-fold at E17.5 
compared to controls.  This hypoplasia phenotype was less severe than that of PBKO, in 
which we previously reported a 10-fold reduction in size due to the loss of exocrine 
acinar cells (Fig. 3.1D).  Likewise, β-cell volume was reduced ~1.3-fold in PBsKOs, a 
less severe phenotype than the ~2.3-fold reduction observed in PBKOs (Fig. 3.1E) 3.  
Together these data indicate that the full measure of pancreas and β-cell mass requires the 
signaling function of β-catenin, but that nonsignaling roles of β-catenin may also 
contribute to pancreas growth.  
 
Antibody staining identifies β-catenin signaling-deficient cells 
 Further characterization of PBsKO mice required the ability to distinguish β-
catenin signaling-deficient cells from “escaper” cells that fail to undergo Cre-mediated 
recombination of Ctnnb1lox and thus retain functional β-catenin protein.  The C-terminal 
deletion engineered into the Ctnnb1DM-encoded protein (henceforth, βCATDM) eliminates 
binding of C-terminus specific antibodies [β-cat(C-term)], whereas antibodies designed 
against the central armadillo protein core [β-cat(ARM)]  will bind both βCATDM and 
βCATWT 6.  We stained control and PBsKO pancreata with both β-cat(ARM) and β-
cat(C-term), along with anti-E-cadherin to label the entire epithelium (Fig 3.2A-L).  As 
expected, control pancreata were stained with both β-cat(ARM) and β-cat(C-term), 






Figure 3.1.  β-catenin signaling is required for embryonic pancreas growth.  
PBsKO pancreata were analyzed and compared to controls at E17.5.  (A) Breeding 
scheme to generate control and PBsKO genotypes. (B-C)  Images of E17.5 control 
and PBsKO pancreata reveal a reduced pancreatic size in PBsKOs.  (D)  Pancreata 
that were stained with E-cadherin (not pictured) were quantified and normalized to 
controls, and exhibit a 3.4-fold reduction in PBsKO compared to controls, whereas 
PBKO were 10-fold smaller than controls.  (E) Quantification of Insulin+ β-cells 
normalized to controls at E17.5 reveals a more severe reduction of β-cell mass in 
PBKO than PBsKO when compared to littermate controls.  The number of pancreata 





Figure 3.2. Antibody staining identifies β-catenin signaling-deficient cells.  E14.5 
control and PBsKO pancreata were stained with antibodies that recognize either the 
central armadillo core (ARM) or the C-terminus (C-term) of β-catenin.  (A-C)  As 
expected, all epithelial cells from control pancreata stained for E-cadherin (red) and 
for full length β-catenin (green).  (D-F) The same field as in (A) is shown stained for 
β-catenin (C-term) which clearly labels all epithelial cells.  (G-I)  All epithelial cells 
are co-labeled by the β-catenin (ARM) antibody in PBsKO.  (J-L)  Potential β-catenin 
signaling-deficient cells are identified by their lack of β-catenin (C-term) staining, 
shown with the open yellow arrowhead.  The closed arrowhead indicates “escaper” 
cells that retain a functional copy of β-catenin stain with both antibodies. 
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catenin protein (Fig. 3.2A-F).  In PBsKO mice, we found that all epithelial cells stained 
with β-cat(ARM) (Fig 3.2G-I), however, numerous clusters of pancreatic epithelial cells  
failed to co-stain with β-cat(C-term) (Fig 3.2J-L), indicating expression of βCATDM but 
not βCATWT.  Therefore, we interpret β-cat(C-term)-negative cells to be β-catenin 
signaling-deficient cells of the pancreatic epithelium.    
 
Functional association of signaling-deficient 
β-catenin with adherens junctions 
 In addition to the canonical role of β-catenin in Wnt signaling, β-catenin also 
stabilizes adherens junctions in the pancreas where it associates with E-cadherin and α- 
catenin.  In the absence of β-catenin function, E-cadherin junctions appear unchanged in 
the pancreas 8,9.  Previous work from our lab and others indicates that another catenin 
family member, plakoglobin (γ-catenin), can act redundantly and stabilize junctions in 
the absence of β-catenin 9,23.  We tested whether the truncated βCATDM protein was still 
found at E-cadherin-associated junctions, or whether it was replaced by plakoglobin as in 
PBKO.  We stained E11.5 PBKO and control pancreata for E-cadherin and plakoglobin 
and, confirming our previous report, observed strong co-localization of E-cadherin and 
plakoglobin at the cell membrane in PBKO but not controls (Fig. 3.3A-F).  To determine 
if plakoglobin was similarly localized at the cell membrane in PBsKO, we stained E11.5 
pancreata with β-cat(C-term) and plakoglobin and observed, in contrast to the PBKO 
phenotype, no detectable increase in plakoglobin staining (Fig. 3.3G-L).  Therefore, we 
infer that structural aspects of β-catenin function are retained in β-catenin signaling- 






Figure 3.3. βCATDM associates with adherens junctions.  Plakoglobin staining was 
performed on E11.5 control, PBKO, and PBsKO pancreata with E-cadherin or β-
catenin.  (A-C) Adherens junctions of E11.5 control pancreatic epithelium stain for E-
cadherin but not plakoglobin.  (D-F) Robust junctional plakoglobin staining is found 
in PBKO epithelium, potentially replacing β-catenin.  (G-I)  All control cells stain for 
β-catenin (C-term) but not plakoglobin at the junctions.  (J-L)  PBsKO pancreata do 
not stain for plakoglobin or β-catenin (C-term). 
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indicate that plakoglobin upregulation in the absence of β-catenin reflects a “sensing”  
mechanism operating at the adherens junction, rather than a signaling-dependent 
feedback mechanism. 
 
β-catenin signaling is not essential for acinar cell development 
 Because epithelial and β-cell volume were not as diminished in PBsKO pancreata 
compared to PBKO pancreata, we were particularly interested in determining whether 
PBKO associated acinar loss also occurs in the PBsKO pancreas.  To examine acinar cell 
development in the absence of β-catenin signaling, we stained late fetal stage PBsKO 
acinar cells for the digestive enzyme amylase and for β-cat(C-term) to distinguish escaper 
cells from potential signaling-deficient acinar cells.  All control acinar cells stained for β-
cat(C-term) as anticipated (Fig. 3.4A-C).  However, we were surprised to find found 
numerous acinar cell lobules in PBsKO pancreata that were devoid of β-cat(C-term) 
staining (Fig 3.4 D-F).   This result was in stark contrast to PBKO tissue, in which nearly 
all acinar cells that develop represent escaper cells that did not delete Ctnnb1lox 9.  These 
observations were confirmed by quantifying the fraction of escaper vs. true knockout 
acini (βCATWT-negative) in PBKO and PBsKO tissues.  We found that 96% of all acini 
in PBKO were escapers, compared to only 44% in PBsKO (Fig 3.4G).  Therefore, we 
conclude that β-catenin signaling is not essential for acinar differentiation.  The fact that 
escaper βCATWT cells do contribute to over half of acinar cells, however, implies a 
selective disadvantage of β-catenin signaling-deficient cells, potentially at the level of 




Figure 3.4. Acinar cells develop in the absence of β-catenin signaling.  E17.5 
pancreata were stained with a β-catenin (C-term) antibody (green) and the digestive 
enzyme amylase (red) to identify potential β-catenin signaling-deficient acinar cells.  
(A-C) Acinar cells, juxtaposed to islets (green), from control pancreata co-stain with 
β-catenin and amylase.  (D-F) Amylase+ β-catenin (C-term)- acinar cells develop in 
PBsKO pancreata at E17.5, along with β-catenin (C-term)+ “escaper” acinar cells. (G) 
The percentage of β-catenin (C-terminal)+/- acini was calculated in PBKOs and 
PBsKOs and revealed that most acini in PBKOs were escapers, whereas less than half 
of all acini in PBsKO were escapers. 
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β-catenin signaling regulates proliferation in distal progenitors  
and acinar cells  
 We and others previously found that β-catenin regulates proliferation of 
pancreatic progenitors during development and acinar cells during postnatal expansion, 
homeostasis, and regeneration, whereas it is not required for β-cell replication 3,8,9,22,24. 
Considering these results, we sought to understand whether the signaling function of β- 
catenin specifically promotes the proliferation of progenitors, acinar precursors, and early 
acinar cells.   To examine the potential requirement for β-catenin signaling in 
proliferation, we injected pregnant mice with BrdU to label proliferating cells 1 hour 
prior to harvest at E12.5 and E14.5, and analyzed BrdU labeling of Cpa1+ 
(carboxypeptidase 1) MPCs at E12.5 (not shown), or early acinar cells at E14.5 (Fig 
3.5A-F).   For the postnatal day 7 (P7) timepoint, we identified proliferating acinar cells 
by immunofluorescence for Ki67 and the digestive enzyme amylase (images not shown).   
Because we used different methods to assay proliferation, we chose to normalize each 
period to the control population of each given time point.  We found that at E12.5, E14.5, 
and P7, control cells consistently proliferated at a rate ~1.3-fold higher that of PBsKO 
cells (Fig. 3.5G).  Again, this difference was less severe than that observed found in 
PBKO, where we found a ~2-fold reduction in proliferation 3.  These results confirmed 
that β-catenin signaling is required for the full extent of pancreas growth.  However, it is 
worth noting that in the absence of β-catenin signaling, a significant level of proliferation 
still occurs, yet the PBsKO pancreas remained hypoplastic compared to controls. 
 Given the change in proliferation between control and signaling-deficient cells, 
we predicted that, similar to PBKO, escaper cells would eventually overtake the PBsKO 
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pancreas.  Using the same strategy as in Figure 3.4G, we calculated the fraction of 
escaper cells found at two additional time points, E14.5 and P7, and found that βCATWT+ 
escapers gradually but steadily overtake mutant cells by P7, eventually making up the 
majority of existing acinar cells (Fig. 3.5H, blue line).  Though a clear trend toward 
escaper take-over was evident from these data, we sought to independently verify that the 
difference in proliferation between escapers and mutant cells could account for our 
observation by simulating pancreas growth with a simple mathematical model (see 
Materials and Methods and Fig 3.6). We used the exponential growth equation, N(t) = 
N(0) * e(r*t)  to predict the rate at which escapers would overtake the acinar population. 
The forecasted escaper percentage tracked closely with empirical data, predicting that the 
majority of acinar cells would be escapers by the postnatal period (Fig. 3.5H, orange 
line).  We also asked whether the difference in proliferation could explain the size 
difference observed at E17.5, when the PBsKO pancreas is ~3.4-fold smaller than 
controls.  We modeled pancreas growth from E11.5, a point previously determined to be 
relatively unchanged in β-catenin mutants 3, and found that the predicted size difference 
followed closely with our observations (Fig. 3.5I).  In each model, the growth equation 
lagged slightly behind the actual differences in escaper percentage and size, reflecting a 
potential limitation of these data.  Nonetheless, these simple mathematical models 
support our empirical data and demonstrate the signficant consequences to organ growth 








Figure 3.5.  β-catenin signaling regulates proliferation in MPCs and acinar cells.  
Control and PBsKO littermates received BrdU 1 hour prior to sacrifice at E12.5 and 
E14.5, while P7 pancreata were stained for Ki67, and proliferation index was assessed 
and normalized to controls.  Proliferating cells are labeled by BrdU or Ki67 
immunostaining (red) and Cpa1 marks distal-tips (green). The absence of β-catenin 
(C-term) immunostaining (i.e., panel F) was used to identify PBsKO cells. (A-C) 
Abundant BrdU+ Cpa1+ control cells were all co-labeled with β-catenin at E14.5.  (D-
F) Fewer Cpa1+ BrdU+ distal tip cells are found in E14.5 PBsKO pancreata in β-
catenin (C-term)- cells.  (G) The proportion of proliferating cells normalized to 
controls is shown at E12.5, E14.5, and P7.  PBsKO cells proliferate at a rate ~1.3-less 
than controls at all assayed time points.  (H)  The percentage of distal-tip/acinar cells 
that were escapers in PBsKOs is shown at E14.5, E17.5, and P7 (blue line), revealing 
a gradual takeover by βCATWT+ cells as development progresses.  A mathematical 
simulation of escaper versus mutant cell percentage is shown plotted on the same 
graph (orange line) beginning at E14.5 where the percentage of escapers was known, 
indicating the likely takeover of escapers.  (I)  The size difference ratio between 
controls and PBsKO pancreata is shown at E12.5 and E17.5 (black dots and blue line).  
The predicted size difference (orange line) between controls and PBsKO closely 


















Figure 3.6. Modeling PBsKO development using exponential growth.  An 
exponential growth formula was used to model PBsKO pancreas growth given the co-
existence of escaper and mutant cells within the pancreatic epithelium.   (A) The 
exponential growth formula that was used to model growth is shown along with the 
definitions of each variable.  We calculated the growth rate constants by utilizing 
empirical data (shown in bold red lettering) we previously obtained in other 
experiments. (B) The percentage of escapers was calculated by dividing their 
predicted number by the total predicted PBsKO pancreas size at t days. (C) Because 
β-catenin has little effect on the E11.5 pancreas, size was modeled by predicting the 
number of escapers present at E11.5 by using known data from E14.5 (shown in red 
lettering), and simulating PBsKO and wild-type growth.   
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β-catenin signaling regulates postnatal acinar cell expansion 
 
 Previous studies demonstrate that β-catenin is critical for postnatal acinar cell 
proliferation and for acinar cell regeneration 8.  To determine whether acinar cell 
proliferation was attributable to β-catenin signaling, we generated acinar specific β-
catenin signaling-deficient mice (ABsKO) using similar breeding schemes as described 
earlier, substituting the tamoxifen mediated acinar-specific Elastase-CreERT transgene 19 
for the Pdx1-Cre transgene.  Importantly, the mice resulting from these crosses all carry 
the Cre-dependent R26REYFP reporter 17, allowing for lineage tracing of recombined cells.   
To delete β-catenin signaling and simultaneously activate the R26REYFP reporter, we gave 
tamoxifen to nursing mothers at birth (P0) and analyzed EYFP labeling 7 or 30 days after 
tamoxifen administration.  Additionally, to assess proliferation, we administered BrdU 1 
hour prior to sacrificing mice at P7 or P30.  At P7, ABsKO mice exhibited a significant 
reduction in the number of BrdU+ EYFP+ acinar cells as compared to controls (Fig. 
3.7A-E).  This result is consistent with previously published results obtained from 
deleting all β-catenin function in acinar cells 8, and support a role for β-catenin signaling 
in juvenile acinar cell proliferation. The decrease in proliferation rate detected by BrdU 
incorporation, in P7 ABsKO mice, appears greater than that previously observed using 
Ki67 staining of P7 PBsKO mice (Fig 3.5G).  We attribute this discrepancy to the 
different methods used to identify proliferating cells, BrdU labeling being strictly specific 
to cells progressing through S-phase while Ki67 is expressed during the entire cell cycle 
and could persist in cells that are not progressing through S-phase due to lack of β-
catenin signaling.  After the postnatal period, at P30, the percentage of EYFP+ acinar 




Figure 3.7. β-catenin signaling is critical for acinar cell proliferation during 
postnatal growth.  (A-D) P7 mice were pulsed with tamoxifen on the day of birth, 
and received a 1-hour pulse of BrdU prior to sacrifice to label proliferating acinar 
cells. Immunofluorescent staining for EYFP+ acinar cells (green) and DAPI stained 
nuclei (blue) labeled by the S-phase marker BrdU (red).   The percentage of 
proliferating EYFP+ BrdU+ cells is decreased in ABsKO mice compared to controls. 
(E) Quantification of the BrdU labeling index of EYFP+ cells reveals a significant 
reduction in the proliferative capacity of β-catenin signaling deficient acini.  (F-G) 
Postnatal day 30 (P30) control or ABsKO mice received tamoxifen on the day of birth 
to induce recombination. Staining for the EYFP lineage (green) of amylase+ acinar 
cells (red) reveals fewer EYFP+ cells in ABsKO pancreata at P30, compared with 
controls. (H) The percentage of EYFP labeling of amylase+ acinar cells is decreased 
in ABsKO mice at P30, indicating that β-catenin signaling deficient acinar cells do not 
efficiently contribute to postnatal expansion of the exocrine pancreas (used with 
permission from Matthew Keefe).   
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proliferative disadvantage favoring the expansion of EYFP-negative escaper cells (Fig. 
3.7F-H).   These data strongly indicate that the signaling function of β-catenin is critical 
for expansion of distal MPCs as well as mature acinar cells, but is likely dispensable for 
the establishment and maintenance of this lineage.  
 
 
β-catenin structural function is partially sufficient for  
distal-proximal patterning 
 In Chapter 2 3, I demonstrated that loss of β-cell mass in PBKO pancreata was not 
due to a defect in the differentiation of endocrine precursors, but instead correlated  
with an early and specific loss of distal MPCs. This result revealed a novel role for β-
catenin, in maintaining proximal–distal patterning of the early epithelium, as distal MPCs 
resorted to a proximal, endocrine-competent “trunk” fate following β-catenin deletion.  In 
addition to a quantitative reduction in total β-cell mass, the loss of MPCs in the PBKO 
pancreas produces a qualitative, near-total depletion of acinar cells.  As acinar cells still 
developed in PBsKO, we hypothesized that distal MPCs would persist in the absence of 
β-catenin signaling function, albeit in a context of reduced proliferation and growth.   
 To determine whether distal-proximal patterning is maintained in PBsKO 
pancreata, we stained and counted putative E12.5 MPCs, labeled by the distal-tip-specific 
marker Ptf1a 14 (Fig 3.8A-B).  We found that although Ptf1a+ MPCs were reduced in 
PBsKO compared to controls, their numbers were significantly increased compared to 
PBKO 3 (Fig 3.8C).  Much of the reduction of MPCs that is observed, in PBsKO, is likely 
due to the overall reduction in epithelial volume, which is similar between PBsKO and 




Figure 3.8.  Patterning is maintained in early PBsKOs.  E12.5 mutant and control 
pancreata were stained for Ptf1a to label distal MPCs, E-cadherin to label all epithelial 
cells, and Ngn3 to label proximal endocrine precursors.  The pancreatic epithelia is 
outlined in red in the images.  (A-B)  Controls stained for Ptf1a pinpoint MPCs 
localized to the distal periphery of the pancreatic epithelium.  Fewer Ptf1a+ cells were 
found in PBsKOs compared to controls.  (C) Quantification of Ptf1a+ cells in controls, 
PBsKO, and PBKO revealed a significant loss of Ptf1a+ cells in mutants compared to 
controls.  However, the drop in Ptf1a+ cells in PBsKO is less severe than in PBKOs.  
(D)  The size of pancreatic epithelium in PBsKO and PBKO are similarly reduced 
compared to controls at E12.5.  (E-F)  Control and PBsKO pancreata stained for the 
endocrine precursor Ngn3, revealed little difference in Ngn3+ staining.  (G) No 
difference in the number of Ngn3+ cells was found between controls and PBsKO.  In 
PBKOs we previously observed a significant increase of Ngn3+ cells compared to 




catenin signaling, Ptf1a+ MPCs are found to localize normally to the periphery of the 
branched epithelium in PBsKO pancreata (Fig. 3.8B).  Together, these data suggest that 
restoring the structural function of β-catenin can rescue MPC patterning defects found in 
PBKO.    We previously found that Ngn3+ pre-endocrine precursors were approximately 
doubled in number in PBKO pancreata at E12.5 3.  By contrast, we found no significant 
increase in Ngn3+ cells in PBsKO, compared to controls (Fig. 3.8E-G).  Together with 
the more tempered loss of Ptf1a+ cells, we interpret these data to indicate that non-
signaling roles of β-catenin make a critical contribution to early tip-trunk patterning in 
the developing pancreas.  
 
Wnt ligands are not necessary for the differentiation  
of acinar or endocrine cells 
 While the source and variety of Wnt ligands involved in pancreas development 
are not known 7, our findings would suggest that canonical β-catenin-mediated Wnt 
ligands should be dispensable for acinar cell development and patterning but important 
for epithelial expansion.  To determine whether Wnt ligands are required to maintain 
patterning, we cultured wild-type E11.5 pancreata in the absence or presence of the Porcn 
inhibitor IWP-2 25.  Porcn is required for secretion and bioactivity of all known Wnt 
ligands 26,27, and its inhibition with IWP-2 in metanephric kidney explants resulted in loss 
of Wnt/β-catenin-dependent branching morphogenesis 28.  We recapitulated this result 
using E11.5 kidney explants treated with 5 µM IWP-2, confirming the efficacy of this 
small molecule as a tool to inhibit Wnt signaling in pancreatic explant culture (Fig. 3.9).  
Dorsal pancreatic bud explants were grown for 3 days in the absence or presence 
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Figure 3.9.  IWP-2 blocks branching in kidney explants.   To confirm the efficacy 
of IWP-2 as a Wnt inhibitor for pancreas explant cultures, E11.5 wild-type kidney 
explants were grown for 4 days in the absence or presence of 5 µM IWP-2.  Explants 
were imaged by bright field imaging and through immunofluorescent staining of E-
cadherin to label the epithelial branches.  (A-B)  Control kidneys grew and readily 
branched into the surrounding kidney mesenchyme.  (C-D)  IWP-2 treated kidneys 
branching was severely inhibited, confirming previous reports and indicating the 
efficacy of this drug.    
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of IWP-2, and stained for the tip/acinar marker Cpa1 and the α-cell marker glucagon.  We 
previously demonstrated that β-catenin-deficient pancreatic epithelia do not generate 
acinar cells under these culture conditions 3.  By contrast, we found that both control and 
IWP-2-treated explants developed Cpa1+ acinar cells as well as glucagon+ cells (Fig. 
3.10A-B).  This in vitro result supports our conclusion, based on PBsKO phenotypes in 
vivo, that the canonical Wnt/β-catenin signaling pathway is not required to maintain 
MPCs or differentiate acinar cells.  
 To directly determine the effects of blocking β-catenin signaling in this explant 
culture system, we cultured control and PBsKO explants as above.  As expected, 
abundant Cpa1+ acinar cells developed in both control and PBsKO explants; importantly, 
the vast majority of these arose in the latter from βCATDM+ progenitors, whereas Cpa1+ 
cells developing in PBKO explants predominantly arose from βCATWT+ escapers (Fig. 
3.10C-I).  By eliminating either Wnt ligand production or β-catenin signaling activity, 
and observing similar phenotypes, our findings indicate that Wnt/β-catenin signaling is 
largely dispensable for pancreatic patterning and acinar cell differentiation, whereas β-




 Previously, we and others found that acinar cell development, postnatal 
expansion, and acinar cell regeneration, but not β-cell differentiation and function, were 
dependent on the multifunctional protein, β-catenin 8,9,22.  Furthermore, in Chapter 2 of 
this dissertation, I demonstrated that β-catenin is required prior to endocrine specification 





Figure 3.10. Patterning is maintained in the absence of Wnt signaling ex vivo.  
(A-B) Wild-type E11.5 dorsal pancreatic buds were cultured for 3 days with or 
without the Porcn inhibitor IWP-2 (5 µM).  IWP-2 treatment reduced overall explant 
size, but did not perturb the normal proportions of Cpa1+ (red) and glucagon+ (green) 
cells. (C-H) Control or PBsKO dorsal bud explants were cultured for 3 days, and 
stained for Cpa1 (red) and β-catenin (C-terminal) (green).  The majority of Cpa1+ 
cells in PBsKO explants lack staining for the β-catenin C-terminus (i.e., express 
βCATDM rather than βCATWT), indicating that β-catenin signaling is not required ex 
vivo for patterning or acinar cell development.  (I) Quantification of the percentage of 
β-catenin (C-term)+ acinar cells in PBsKO and PBKO.  Together, these data indicate 
that Wnt/β-catenin signaling is not required for acinar cell development ex vivo.   
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two distinct roles for β-catenin during pancreas development: first, it promotes and 
maintains distal-proximal patterning of the epithelium by inhibiting Notch function, and   
second, it is required for the full measure of proliferation in the early epithelium 3.  
However, these studies could not determine whether the two distinct roles for β-catenin, 
patterning and proliferation, were mediated by its signaling or structural functions.   In 
the present study, we re-address the role of β-catenin in pancreas development by 
utilizing a signaling-deficient, yet structurally competent allele of β-catenin (Ctnnb1DM) 6. 
We infer that the signaling and structural functions of β-catenin are required separately 
for the maximal proliferation and growth of the organ, and to maintain distal-proximal 
patterning and acinar cell differentiation, respectively.  The evidence presented in this 
chapter offers a new perspective of β-catenin during pancreas development, assigning the 
signaling and structural roles of the protein to proliferation and patterning, respectively 
(Fig. 3.11).   
  Whereas prior studies eliminating both the Wnt signaling and structural function 
of β-catenin just after specification (PBKO) resulted in the loss of acinar cell 
differentiation and expansion 9,22 inhibition of Wnt ligand signaling, through the  
expression of a soluble, dominant-negative Frizzled8 Wnt receptor, impeded proliferation 
but did not prevent acinar cell differentiation or pancreatic function 29.  Moreover, 
deleting β-catenin from the pancreatic epithelium beginning several days after 
specification, when many MPCs are already acinar restricted, does not prevent acinar cell 
development, but does negatively affect proliferation 24.  Previously, we also found that 
acinar-specific deletion of β-catenin after birth does not alter functionality or acinar cell  




   
Figure 3.11. Multiple roles for β-catenin during early pancreas development.  
Following specification and prior to E12.5, MPCs (purple) are relatively unorganized, 
until a dramatic shift in morphology occurs referred to here as patterning.  After E12.5 
MPCs are found at the distal-tip of the pancreatic epithelium (shaded purple) and 
proximal-trunks (shaded grey) comprise trunk progenitors and Ngn3+ endocrine 
precursors.  A new role for β-catenin in maintaining the distal-proximal patterning of 
early pancreatic progenitors has been identified, indicated by the blue dashed line 
between the two domains at E12.5.  Evidence suggests that the structural role of β-
catenin (blue lettering/arrows) mediates this process.  The signaling role of β-catenin 
(green lettering/arrows) is required for pancreatic growth and proliferation of the distal 
and proximal cells during early phases of development and during acinar postnatal 
acinar cell expansion.  Black arrows indicate proliferation occurring independent of β-
catenin.   
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supporting a progrowth role for β-catenin in acinar cells 8. These data suggest that, once 
cell fates are committed, acinar cell development proceeds independent of β-catenin, but 
that maximal proliferation requires β-catenin.  In Chapter 2, I showed that the loss of 
acinar cells in PBKO is reflected by an early and dramatic loss of uncommitted MPCs 
and disrupted distal-proximal patterning 3.  Here, we provide direct evidence showing 
that the Wnt signaling function of β-catenin is dispensable for acinar cell development 
but is required for maximal proliferation in utero and during the postnatal period.  
Furthermore, we found that distal-proximal patterning in PBsKO pancreata was 
maintained compared to that observed in PBKOs.  Nonetheless, there were fewer Ptf1a+ 
distal cells in PBsKO compared to control, which we attribute to the loss in proliferation 
and the natural transition from MPC to bi-potent trunk progenitor. Finally, the reduction 
of β-cell mass in PBsKO was less dramatic than that observed in PBKO.  We believe that 
the combined disruption of patterning and proliferation aggravates the β-cell development 
defect in PBKO pancreata, likely secondary to the dramatic loss of MPCs, whereas in 
PBsKO pancreata, the reduction in β-cell mass is due primarily to decreased proliferation 
of otherwise normally patterned progenitor cells. 
 Decades-old studies of rodent ex vivo pancreas development have emphasized the 
importance of extrinsic signals originating from pancreatic mesenchyme for exocrine 
growth 30,31.  Coupled with the obvious defects in the exocrine pancreas in the absence of 
β-catenin 9,22, we speculated that Wnts from pancreatic mesenchyme are necessary for 
distal-acinar cell growth.   However, eliminating all Wnt ligands genetically is 
complicated by redundancy and all potential sources of Wnts have not been identified 
during pancreas development 7.  The acyltransferase Porcn is necessary for the secretion 
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and bioactivity of all Wnt ligands, such that eliminating its activity results in the loss of 
all Wnt ligand activity 26,27.  To evade the aforementioned issues with eliminating Wnt 
ligands genetically, we cultured pancreatic explants ex vivo in the presence of the Porcn 
inhibitor IWP-2, thereby rendering treated explants Wnt signaling-deficient, and found 
that distal/acinar development proceeded normally.  Together, these data support a model 
wherein Wnt/β-catenin signaling primarily functions to drive maximal proliferation in 
both the early epithelium and in acinar cells, while proximal-distal patterning and acinar 
development rely on the structural role of β-catenin. 
 One potential caveat to this conclusion derives from the approach we have used to 
disrupt Wnt/β-catenin signaling.  The Ctnnb1DM allele has been thoroughly characterized 
in vitro and in vivo, and found to reduce Wnt/β-catenin signaling activity equivalently to 
a β-catenin null in both Drosophila and mammals 6.  Nonetheless, the βCATDM protein 
retains its TCF-binding domain and could potentially enter the nucleus and bind to these 
transcription factors.  One of these, Tcf3/Tcf7L1, is thought to be regulated at the level of 
derepression rather than activation 32,33, and might be derepressed by βCATDM binding 
even if co-activators cannot by recruited.  A mouse mutant of Tcf3 was recently 
developed that cannot bind β-catenin (Tcf3ΔN), and identifies phenotypes that depend on 
this derepressive mechanism 33.  We examined Tcf3ΔN/ΔN embryos and did not observe 
any pancreatic abnormalities, consistent with the lack of detectable Tcf3 expression 
during pancreas development 9.  We therefore conclude that although βCATDM could still 
potentially bind to and derepress TCF factors, this mechanism is unlikely to compensate 
for loss of β-catenin-dependent activation in PBsKO pancreata.   Nevertheless, future 
experiments are necessary to confirm that Wnt/β-catenin signaling is absent from the 
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pancreas in βCATDM animals. 
 The concept that β-catenin plays multiple, mechanistically-independent roles 
during organogenesis is not without precedent.  In the neural tube, the signaling and 
structural roles of β-catenin perform separate but critical roles during development 6.   At 
a cell biological level, what might be the structural function of β-catenin in pancreas 
development?  In our work investigating PBKO as well as acinar-specific β-catenin 
mutants (ABKO), we showed that despite the loss of β-catenin at the cell-cell junctions, 
E-cadherin localization appears normal 8,9.  We and others have shown that in the absence 
of β-catenin the desmosomal protein γ-catenin/plakoglobin is upregulated and localizes to 
E-cadherin+ adherens junctions, presumably acting redundantly to stabilize epithelial 
structures 9,23.  In this chapter, we demonstrated that the loss of β-catenin signaling did 
not induce upregulation or junctional localization of plakoglobin.  We therefore assume 
that any yet-to-be-determined changes found in PBKO do not exist in PBsKO.  As β-
catenin links with the actin cytoskeleton via α-catenin, whether subtle, cytoskeletal 
changes occur when plakoglobin takes the place of β-catenin remains to be determined.  
Nevertheless, we are tempted to speculate that actin dynamics could be altered in 
PBKOs.  The pancreas-specific deletion of the cytoskeletal regulator Cdc42 alters 
patterning, as evidenced by an increased number of undifferentiated MPCs caused by 
changes to polarity 11.   Such polarity defects led to failed ductal tube formation and 
increased epithelial-mesenchymal contact points, potentially enhancing MPC 
maintenance and acinar cell development 11,30.    
 We speculate that the loss of β-catenin at adherens junctions negatively affects 
actin dynamics, despite apparently normal E-cadherin localization, causing the observed 
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changes to patterning found in PBKO but not PBsKO.  Moreover, determining that the 
signaling and structural functions of β-catenin are both necessary for separate aspects of 
pancreas development will stimulate further inquiry into other β-catenin loss-of-function 
phenotypes in which these two roles have not been distinguished.  Finally, defining that 
pancreas development requires exact spatiotemporal control of both β-catenin functions 
could enhance future efforts to generate cell-based therapies for pancreatic diseases such 
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SUMMARY AND CONCLUSIONS  
 
 The autoimmune destruction or dysfunction of pancreatic β-cells results in 
diabetes, which may be reversed at least transiently by the addition of new β-cells.  
Although functional β-cells can be obtained from cadaver donors, their availability is 
limited and insufficient to treat all insulin-dependent diabetics, and strategies to expand 
their numbers have met with only limited success to date.  With their capacity for 
multilineage differentiation, pluripotent stem cells stand as a potentially inexhaustible 
source of β-cells; nonetheless, the milieu of signals and factors that drive β-cell 
development are not completely known. Exploiting the mechanisms controlling 
pancreatic organogenesis, and specifying progenitor lineages, will assist efforts to 
generate β-cells from stem cells for the purpose of treating diabetes.  The work presented 
in this dissertation concentrates on the role of the multifunctional protein β-catenin during 
pancreas development, particularly during β-cell development. Therefore, the objectives 
of this dissertation were as follows:  (1) To determine the role of β-catenin during β-cell 
development;  (2)  To elucidate the cellular mechanisms by which β-catenin controls the 
allocation of pancreatic lineages;  (3)  To distinguish if the Wnt signaling or structural 




 At the outset of my studies, the role of β-catenin during pancreas development 
was controversial 1.  Whereas some studies found that β-catenin was selectively required 
for exocrine acinar cell but not for endocrine β-cell development 2,3, others suggested that 
the Wnt signaling role of β-catenin was necessary for islet cell development 4.  These 
discordant results might be explained by several factors: First, the Pdx1-Cre deletor 
strains used to eliminate β-catenin were active either early, with no reported β-cell 
defects, or later with defects in islet cell number.  Second, islet cell numbers were not 
accurately or thoroughly assessed in previous studies. Previously, β-cell mass was 
calculated by dividing the endocrine area by the total area of the pancreas, as measured 
across several representative sections.  Such an approach, however, does not account for 
the loss of other pancreatic tissue such as acinar cells, potentially skewing the actual 
number of β-cells present 5.  Therefore, I developed a strategy to more accurately 
quantify the absolute mass or number of cell types in the pancreas, instead of their 
relative volume.  The result of this strategy, presented in Chapter 2, was the confirmation 
of acinar cell and pancreatic hypoplasia and discovery of a more drastic reduction of β-
cells than previously appreciated 6.  But why were fewer β-cells present, given that they 
appear to differentiate, function, and proliferate normally in the absence of β-catenin 2,3,7?  
Where and when during development was β-catenin required to establish normal β-cell 
mass?  By deleting β-catenin specifically from Ngn3+ islet precursors 8, which revealed 
no change in islet cell mass, I determined that β-catenin acts prior to endocrine 
specification to establish β-cell mass.  Given these results, and because all pancreatic 
lineages arise from multipotent progenitor cells (MPCs) whose numbers determine organ 
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size 9-11, I hypothesized that the loss of β-cells in β-catenin deficient pancreata was due to 
the loss of MPCs. 
 By measuring pancreas size at various points during in utero development, I 
determined that the loss of β-catenin had little effect on pancreatic mass prior to E12.5. 
This finding is consistent with a previous study that reported pancreatic agenesis when β-
catenin was ectopically activated prior to E12.5 12, and suggests that the major role of β-
catenin plays out after initial organ specification and bud formation.  In fact, at E11.5 we 
found no difference in the number of MPCs present in PBKO and controls, providing 
evidence that the initial specification, patterning, and proliferation of MPCs occurs 
without β-catenin activity.  However, just one day later at E12.5, the number of MPCs 
was dramatically reduced.  Notably, the loss of MPCs from E11.5 to E12.5 coincided 
with an observed increase in Ngn3+ cells, indicating a failure to maintain distal-proximal 
patterning of the early organ, thus identifying a previously undescribed role for β-catenin 
during pancreas development.  This early and specific loss of MPCs likely explains the 
specific loss of exocrine acinar cells reported by separate studies, as distal MPCs are 
eventually restricted to the acinar lineage 2,3,9.  The early proximalization of the β-
catenin-deficient pancreatic epithelium occurred independent of impaired cell division 
that also occurred after E11.5 in both distal-proximal progenitor cells.  This latter result 
may reflect the observed loss of the Wnt/β-catenin target gene cMyc, previously found to 
be necessary for robust pancreatic proliferation 13,14.  Therefore, we conclude that the 
defect in β-cell mass found at the end of development in PBKO was due to a combination 
of a shift in distal-proximal patterning and the reduced proliferation of progenitors, 
together leading to the selective loss of an effective progenitor pool.   
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 Shifts in distal-proximal patterning, or changes to the allocation of pancreatic 
lineages are not restricted to β-catenin mutants.  These have been seen in knockout 
studies of several pancreatic transcription factors, including the trunk determinant Nkx6.1 
and the tip/acinar determinant Ptf1a 15.  Less is known about intercellular interactions that 
control distal-proximal patterning, although recent evidence implicates the Notch 
signaling pathway in this process.  Initial studies of Notch signaling in the developing 
pancreas indicated that this pathway inhibits both endocrine and acinar cell 
differentiation 16-20.  More recent reports suggest that acinar inhibition by Notch could be 
due to effects on distal-proximal patterning, where Notch activity promotes proximal 
over distal fate as well as duct over endocrine fate 15,21,22.  Given our results indicating 
that β-catenin is required to maintain distal identity, and other reports suggesting that 
Notch inhibits distal fate in MPCs at roughly the same developmental stages, I 
hypothesized that the two pathways communicate to pattern the organ.  A previous study 
used the γ-secretase inhibitor DBZ to inhibit Notch activity in pancreatic explants and 
found an expansion of the distal domain 22, suggesting that Notch activity promotes 
proximal fates even ex vivo.  By culturing PBKO explants in the presence of DBZ, I was 
able to inhibit Notch signaling in the context of β-catenin deletion to test whether the two 
pathways interacted.  In contrast to untreated PBKO explants, which developed very few 
β-catenin-deficient acinar cells, I found abundant β-catenin-deficient acinar cells in 
PBKO explants treated with DBZ.  Therefore, inhibiting Notch signaling in the absence 
of β-catenin rescued distal patterning, potentially uncovering an antagonistic relationship 
between the two pathways, wherein β-catenin inhibits Notch activity.  Cooperation 
between these two pathways is not without precedent, and has been extensively studied in 
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colorectal cancer 23.  Inhibitory crosstalk between β-catenin and Notch has not been 
described in the context of pancreas development.   
 How might β-catenin inhibit Notch signaling?  One possibility might be through 
Dishevelled proteins, which are activated by both canonical and noncanonical Wnt 
ligands 24, and have been shown to block Notch signaling in the developing Xenopus 
epidermis through inhibition of the Notch transcription factor partner CSL/RBPJ 25. 
However, β-catenin acts downstream of Dishevelled, and its deletion would not be 
predicted to prevent Dishevelled-CSL interactions.  β-catenin could also negatively 
regulate the expression or localization of Notch signaling components and transcription 
factors, such that its deletion would result in overactivation of Notch to drive epithelial 
proximalization.  Alternatively, β-catenin activity could directly or indirectly regulate the 
expression of Notch target genes such as Hes1, a known regulator of pancreas 
development 17,26.  Finally, the epistatic relationship proposed above does not exclude the 
possibility that these pathways act in parallel, and converge on a yet-unidentified 
downstream mechanism.  Future experiments can distinguish between these models by 
analyzing the expression of Notch signaling components and target genes in the context 
of modified pancreatic β-catenin activity. 
 As a central participant in Wnt signaling and as a component of cadherin-based 
junctions, β-catenin is a multifunctional protein.  However, the use of total β-catenin 
deletion in my studies of β-catenin in patterning and proliferation, described in Chapter 2, 
left open the question of whether these roles could be attributed to signaling or structural 
functions of β-catenin.  Direct inhibition of the Wnt signaling pathway through the 
expression of a dominant-negative Frizzled8 Wnt receptor protein 27, or the deletion of 
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the Wnt target gene cMyc 13,14, reduced proliferation but did not clearly affect early 
patterning or the differentiation of MPCs into multiple pancreatic lineages.  In light of 
these findings and my own from Chapter 2, we proposed that the canonical Wnt signaling 
role of β-catenin promotes proliferation and that the structural role of β-catenin could 
regulate patterning. However, proper genetic tools did not exist until recently to separate 
the signaling and structural functions of β-catenin. Through the utilization of a signaling-
deficient, yet structurally competent allele of β-catenin (Ctnnb1DM) 28, in Chapter 3, we 
addressed these two functions in pancreas development.   
   Wnt/β-catenin signaling-deficient pancreata (PBsKO) exhibited an obvious 
growth defect, appearing similar to PBKO at the end of development; however, further 
investigation revealed major differences in patterning and cell-differentiation between 
these models.  As described previously, although some acinar cells develop in PBKO, 
these nearly all retain a functional copy of β-catenin, having “escaped” Pdx1-Cre 
recombination 2,3.  Conversely, less than half of all acini found in PBsKO were escapers, 
suggesting that acinar cell development and potentially pancreatic distal-proximal 
patterning occur independent of β-catenin signaling.  Analyzing PBsKO, where β-catenin 
structural function had been “restored” compared to PBKO in which no β-catenin 
function is present, revealed a near 2-fold increase in the number of Ptf1a+ cells found at 
E12.5, indicating that distal-proximal patterning was partially rescued and maintained 
when the structural function of β-catenin was active.  Moreover, proliferation was 
abrogated, but not entirely eliminated, in the absence of β-catenin signaling, both during 
early organogenesis and in postnatal acinar cells as shown in Chapter 3, explaining the 
loss of epithelial volume and indicating that Wnt/β-catenin signaling is required for 
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maximal but not absolute proliferation in the pancreas.  Through the use of a 
mathematical model for pancreas growth, we demonstrated that even the modest change 
in proliferation found in PBsKO could account for the dramatic size discrepancy found 
later in development and adulthood. 
 Due to genetic redundancy and unknown cellular sources, whether Wnt ligands 
are actually required for pancreatic growth, or at some level for patterning, has not been 
addressed 1.  We eliminated all Wnt ligands from pancreatic buds, comprising pancreatic 
mesenchyme and epithelia by culturing E11.5 pancreatic buds in the presence of IWP-229, 
a potent inhibitor of the Wnt modifier PORCN, which is needed for the secretion and 
activity of all Wnt ligands 30.  The resulting explants contained both distal and proximal 
populations, further supporting our hypothesis that distal-proximal patterning depends not 
on canonical Wnt/β-catenin signaling, but more likely on structural functions of β-
catenin.  Nevertheless, Wnt/β-catenin signaling remains crucial for the maximal 
proliferation and growth of the developing organ.  In Chapter 2, I demonstrated reduced 
expression in PBKO of the Wnt target gene cMyc, which itself is required for pancreatic 
progenitor and acinar cell proliferation but not maintenance 13.  Therefore, a model in 
which Wnt-dependent cMyc expression drives organ growth is plausible.  However, the 
source of the Wnt ligands that drive pancreas growth throughout in utero development 
and in adulthood 7 cannot be determined through pharmaceutical inhibition as discussed 
above, and remains unknown. 
 At the onset of pancreas development, epithelial buds expand into pancreatic 
mesenchyme, which studies from the 1960s identified as a potential source of extrinsic 
signals that promote exocrine pancreas growth and differentiation 31,32.  Because the 
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obvious defects in acinar cell growth found in PBKO 2,3, PBsKO (Chapter 3), and cMyc 
mutants mimic those found after the removal of pancreatic mesenchyme, we speculate 
that mesenchymally-derived Wnts promote acinar cell proliferation.  In addition, as 
discussed in the Appendix of this dissertation, the pancreatic epithelium may also serve 
as a potential source of Wnt ligands needed for maximal pancreas growth.  
Understanding the source and variety of Wnt signals that drive pancreatic progenitor 
expansion, independent of patterning or lineage specification, could enhance efforts to 
derive β-cells from pluripotent stem cells.  Nonetheless, the mesenchyme must promote 
acinar development via Wnt-independent mechanisms as well, given that acinar cells still 
develop in cultured PBsKO explants but not mesenchyme-deficient explants 31,32.  It will 
be interesting to determine if the primary effect of these mesenchymal signals is on 
proximal-distal patterning, potentially modulated by β-catenin structural function. 
 The notion that the structural and signaling functions of β-catenin exert 
independent and important effects on organ development was first shown, using 
Ctnnb1DM, in the developing spinal cord 28.  However, what the structural role of β-
catenin might be during pancreas development remains elusive.  No defects in E-cadherin 
localization were observed occurred following deletion of β-catenin in the pancreas 3,7.  
This is likely the result of the upregulation and redundant activity of the desmosomal 
protein γ-catenin/plakoglobin localizing to E-cadherin junctions 3,33.  Such upregulation 
was confirmed in PBKO but not PBsKO samples, leading us to infer that structural 
integrity remains intact in PBsKO.  It is tempting to speculate that the association of 
plakoglobin with E-cadherin could potentially destabilize desmosomal junctions, which 
have been shown to regulate growth and branching in mammary cells, 34 and thereby 
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partially explain the discrepancy between PBKO and PBsKO.  Nevertheless, the actin 
cytoskeleton is linked to E-cadherin through β-catenin, and whether any cytoskeletal 
changes occur in the absence of β-catenin has not been determined.   
 Several revealing studies indicate that actin dynamics and cellular polarity are 
crucial for the maintenance of distal-proximal patterning.  Deleting the cytoskeletal 
regulator Cdc42  from the developing pancreas alters epithelial tube formation by trunk 
cells, and causes increased epithelial-mesenchymal contacts, an interaction that is likely 
crucial for acinar cell development and MPC maintenance 31,35. Furthermore, other 
studies showed that changes to polarity, coordinated in part by the Rho GTPase-
activating protein (Rho-GAP) Stard13 and the EphB2/B3 receptors, are needed to 
generate and maintain the distal-proximal pattern of the early pancreas, and that 
disruptions to epithelial polarization adversely affect pancreas development 36,37.  How 
could changes in actin reorganization lead to changes in distal-proximal patterning?  One 
possibility is that alterations of the cytoskeleton could affect localization or activity of 
Notch ligands or receptors, producing patterning abnormalities such as enriched distal 
patterning observed following Notch inhibition 21,22.  Characterization of the cytoskeletal 
changes present in PBKO but not PBsKO will provide a basis for future investigation of 
this important problem.  
 Together, the data presented in the preceding chapters of this dissertation provide 
a new model for the function of β-catenin during pancreas development (Fig. 4.1).  We 
found that β-catenin is required to establish β-cell mass by maintaining distal-proximal 
patterning, and by expanding the progenitor pool.  In so doing, we clarify previously 
conflicting accounts of the role of β-catenin during β-cell development 1.  Furthermore, 
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we established that pancreatic specification and initial outgrowth occur independent of β-
catenin activity.  Nevertheless, a transition to β-catenin dependence, the basis for which is 
not known, occurs simultaneously with morphological changes to the pancreatic 
epithelium that establish distal-proximal domains 10.  We speculate that once fate is 
established, β-catenin is no longer required to maintain cellular identity, instead 
functioning primarily to drive proliferation. In addition, for the first time, the signaling 
and structural functions of β-catenin during pancreas development have been separated 
and assigned pro-growth and patterning roles, respectively.  Therefore, precise 
spatiotemporal control of both the signaling and structural function of β-catenin is crucial 
to the development of all pancreatic lineages. 
 Future attempts to generate functional β-cells from pluripotent stem cells in vitro 
will require a deeper understanding of the extrinsic and intrinsic mechanisms that govern 
pancreas development.  The information presented in this dissertation proposes that the 
time-appropriate addition of Wnt ligands, and the potential small molecule manipulation 
of β-catenin-mediated structural functions, could be key to the expansion and cell fate 
determination of stem cell-derived pancreatic progenitors, respectively.  Consequently, 
programming β-cell fate will benefit from these and future studies of the mechanisms 














Figure 4.1:  The roles of β-catenin during pancreas development.  Following 
specification and prior to E12.5, MPCs (purple) are relatively unorganized, until a 
dramatic shift in morphology occurs referred to here as patterning.  After E12.5, 
MPCs are found at the distal-tip of the pancreatic epithelium (shaded purple) and 
proximal-trunks (shaded grey) comprise trunk progenitors and Ngn3+ endocrine 
precursors.  A new role for β-catenin in maintaining the distal-proximal patterning of 
early pancreatic progenitors has been identified, indicated by the blue dashed line 
between the two domains at E12.5.  Evidence suggests that the structural role of β-
catenin (blue lettering/arrows) mediates this process and we hypothesize that this is 
performed, in part, through negative regulation of Notch signaling.  The signaling role 
of β-catenin (green lettering/arrows) is required for pancreatic growth and 
proliferation of the distal and proximal cells during early phases of development and 
during acinar postnatal acinar cell expansion.  Black arrows indicate proliferation 
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WNT/β-CATENIN SIGNALING INHIBITS ADIPOGENESIS  
IN THE ADULT PANCREAS 
 
Generated in collaboration with Rachel Redman Hulse, M.S. 
 
Results 
 Previous studies, along with the data presented in this thesis, indicate that the 
canonical Wnt/β-catenin signaling pathway directs various aspects of pancreas 
development 1-3.  As the majority of these studies manipulated Wnt signaling by mutating 
signaling components in the Wnt receiving cells, direct evidence for Wnt ligand activity 
in the pancreas has not been determined.  Moreover, genetic redundancy amongst Wnt 
ligands prevents straightforward examination of individual Wnts and complicates studies 
aimed at identifying potential sources of Wnt signals.  However, all Wnt ligand secretion 
and activity requires the function of a single endoplasmic reticulum-localized 
acyltransferase enzyme Porcupine/Porcn 4. Recently, the Murtaugh lab generated a 
conditional Porcn knockout allele, deletion of which prevents Wnt secretion 5, providing 
a tool to assay ligand-dependent aspects of Wnt signaling. 
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 To determine the role of epithelial derived Wnts during pancreatic organogenesis, 
we deleted Porcnlox 5 from the early pancreatic progenitors with Pdx1-Cre 6 to create 
pancreas specific Porcn knockouts (PPKO).  In contrast to β-catenin mutants, casual 
observation revealed no obvious defect in the pancreatic epithelium near birth (data not 
shown), indicating that epithelial-derived Wnts are not necessary for pancreas 
development in utero.  In addition to its developmental role, β-catenin activity is also 
required for acinar cell expansion following birth 1; nevertheless, whether epithelial-
derived Wnts were required for postnatal pancreas growth and homeostasis was not 
known.  Our analysis of adult PPKO mice revealed that their pancreata were reduced in 
mass compared to sibling controls (data not shown).  However, in histological analysis of 
3-month-old PPKO mice, we unexpectedly discovered the presence of numerous 
adipocytes located within exocrine pancreas lobules.  Intrapancreatic adipocytes were 
even more abundant, apparently replacing acinar cells, at 6 months of age, but were not 
detectable in 1-month-old PPKO mice (Fig. A.1A-F).    
 To determine when adipocytes form within the adult pancreas, we examined 
PPKO mice between 3 weeks and 6 months of age.  We found that intrapancreatic 
adipocytes were not present prior to 2 months of age, but increased progressively from 2 
to 6 months to occupy >50% of the exocrine pancreas (Fig. A.1G).  Many studies have 
shown that Wnt signaling inhibits adipogenesis in vitro 7, and these data provide evidence 
that Wnts from the pancreatic epithelium prevent adipogenesis in the adult pancreas.  
However, which cell type receives Wnt signals to prevent such adipogenesis could not be 
determined in PPKO, as Wnts could have both autocrine and paracrine effects. 
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Figure A.1. Adipocytes form in adult Porcn deficient pancreata. Pancreas-specific 
Porcn knockouts (PPKO) were harvested at several points after birth, stained by H&E, 
and the percentage of adipocytes quantified.  (A-B) One-month-old control and PPKO 
pancreata did not contain intrapancreatic adipocytes.  (C-D) Adipocytes are present in 
3-month-old PPKO pancreata but not controls.  (E-F) At six months, entire lobules of 
pancreatic tissue are inundated with adipocytes in PPKOs.  (G) Quantification of the 
percentage of pancreatic area containing normal acinar cells (blue portion of bar) or 
adipocytes (red portion of bars) from 3 weeks through 6 months of age reveals an 
increasing trend of adipogenesis in the adult PPKO pancreas.   
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 In Chapter 3, we found that acinar cells develop in the absence of Wnt/β-catenin 
signaling, but not in the absence of total β-catenin function 2,8.  Therefore, Wnt signaling-
deficient acinar cells provided a new opportunity to test whether acinar-autonomous Wnt 
signaling suppresses adipogenesis, arising either from epithelial transdifferentiation or 
adipocyte differentiation by some other nonepithelial cell type.  We harvested β-catenin 
signaling-deficient pancreata (PBsKO) from 4-5-month-old mice and, unexpectedly, 
found adipocytes developing within the exocrine domain of β-catenin-negative lobules 
(Fig. A.2A-F). This phenotype was strikingly similar to that observed in PPKO mice of 
similar age.  Moreover, in a separate study, pancreas-specific deletion of c-Myc, a known 
Wnt target gene, also resulted in the appearance of adipocytes9, supporting the notion that 
Wnt signaling within pancreatic epithelial cells is necessary to suppress adipogenesis.  It 
remains unknown whether these adipocytes arose from acinar cells, which would 
constitute an unprecedented endoderm-to-mesoderm cell fate switch, or from non-
epithelial cells (e.g., pancreatic stellate cells), whose differentiation was prevented non-
cell-autonomously by Wnt/β-catenin signaling within adjacent epithelial cells.  
Importantly, lineage tracing of adipocytes in Porcn mutant pancreata (PPKO) indicated 
that they arose from nonepithelial cells, supporting the latter mechanism (R. Hulse, 
unpublished results).  Future experiments will utilize lineage tracing to determine the 
cellular origin of these adipocytes developing in PBsKO pancreata.  In any event, 
although the physiological or metabolic impact of intrapancreatic adipocytes is not 
known, eliminating Wnt/β-catenin signaling from the pancreatic epithelium could serve 
as model to study this phenomenon.    




Figure A.2.  Intrapancreatic adipocytes form in the absence of β-catenin 
signaling function.  Mice 4-5 months of age were harvested and stained 
histologically to identify adipocytes and adjacent sections stained for β-catenin to 
distinguish β-catenin- mutant cells from β-catenin+ escapers.  (A-B)  Rare adipocytes 
are found in β-catenin+ adult pancreata.  (C-F) Fields from two separate 4-5-month-
old PBsKO pancreata showing adipogenesis within the pancreatic epithelium. (D, F) 
Adjacent sections from C and E, respectively, stained for β-catenin that adipocytes 
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